PUBLISHER: Value Market Research | PRODUCT CODE: 1352917
PUBLISHER: Value Market Research | PRODUCT CODE: 1352917
The global demand for Smoking Cessation and Nicotine De-Addiction Market is presumed to reach the market size of nearly USD 39.15 BN by 2030 from USD 13.76 BN in 2022 with a CAGR of 12.32% under the study period 2023 - 2030 .
Smoking cessation and nicotine de-addiction are methods that help cigarette addicts stop smoking. The products and therapies are highly sought after as smoking is injurious to health as well as the environment. Different therapies have also been developed for smoking cessation and nicotine de-addiction goods. This has been sparked by companies introducing treatments for quitting. Some of the well-known nicotine replacement therapy (NRT) product brands on the market for smoking cessation and nicotine de-addiction aids include Nicotex, Nicogum, Smokefree, and KwikNic. A key contributing factor to increased cigarette sales is nicotine addiction. As a result, the market is marketed with nicotine de-addiction goods, including nicotine gum and patches.
The worldwide demand for smoking cessation aids has dramatically expanded the Smoking cessation and nicotine de-addiction market as more people try to give up smoking. The market is also anticipated to grow due to the rising demand for e-cigarettes and nicotine de-addiction products. However, the market players may face significant obstacles, such as product recalls by the manufacturer and companies due to increased technical issues and health risks connected to devices. Nonetheless, an increasing number of people and government are getting concerned about the general health of the public and the environment. Thus, propelling the market forward.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of smoking cessation and nicotine de-addiction. The growth and trends of smoking cessation and nicotine de-addiction industry provide a holistic approach to this study.
This section of the smoking cessation and nicotine de-addiction market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
This section covers the regional outlook, which accentuates current and future demand for the Smoking Cessation and Nicotine De-Addiction market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the smoking cessation and nicotine de-addiction market include 22nd Century Group Inc., Alkalon A/S, Cipla Ltd., GlaxoSmithKline plc (GSK), ITC Ltd., Johnson & Johnson (J&J), JUUL Labs Inc., Pfizer Inc., Strides Pharma Science Ltd., Takeda Pharmaceutical Company Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.